/images/ppid_59c68470-image-176960265102865624.webp)
What is the story about?
Healthcare chain Rainbow Children’s Medicare Ltd
posted a steady December quarter, driven by higher occupancy and steady procedural mix, though margins saw a mild YoY taper.
The pediatric multi-speciality and perinatal care hospital’s net profit (PAT) rose 5.6% YoY to ₹72.5 crore in the quarter ended 31 December 2025 (Q3 FY26) versus ₹68.6 crore a year earlier.
Operating revenue increased 12% YoY to ₹445.4 crore, up from ₹398 crore in Q3 FY25, while total income came in at ₹455.9 crore against ₹411.3 crore YoY.
EBITDA grew 9.5% YoY to ₹146.9 crore compared to ₹134.2 crore in the year-ago quarter. The EBITDA margin stood at 32.9%, down from 33.7% YoY, reflecting a modest dilution in operating leverage.
Total expenses rose to ₹358.3 crore versus ₹317 crore in the same quarter of the previous fiscal year.
Breaking down the cost structure for the quarter, professional fees to doctors constituted the largest cost head at ₹1,080.6 crore, underscoring the company’s doctor-driven care model. This was followed by cost of materials consumed at ₹603.3 crore, employee benefits at ₹600.6 crore among others.
For the nine-month period ended December 2025, the company posted PAT of ₹2,033 crore, up from ₹1,876 crore in the comparable period, while total income reached ₹1,281.9 crore, versus ₹1,182.2 crore a year ago.
In a separate exchange filing, the company said that it launched a new 90-bed hospital in Electronic City, Bengaluru, marking its fifth facility in the city, as it expands regional capacity and network density.
Shares of Rainbow Children’s Medicare ended the day 0.04% below at ₹1,188 on the NSE.
The pediatric multi-speciality and perinatal care hospital’s net profit (PAT) rose 5.6% YoY to ₹72.5 crore in the quarter ended 31 December 2025 (Q3 FY26) versus ₹68.6 crore a year earlier.
Operating revenue increased 12% YoY to ₹445.4 crore, up from ₹398 crore in Q3 FY25, while total income came in at ₹455.9 crore against ₹411.3 crore YoY.
EBITDA grew 9.5% YoY to ₹146.9 crore compared to ₹134.2 crore in the year-ago quarter. The EBITDA margin stood at 32.9%, down from 33.7% YoY, reflecting a modest dilution in operating leverage.
Total expenses rose to ₹358.3 crore versus ₹317 crore in the same quarter of the previous fiscal year.
Breaking down the cost structure for the quarter, professional fees to doctors constituted the largest cost head at ₹1,080.6 crore, underscoring the company’s doctor-driven care model. This was followed by cost of materials consumed at ₹603.3 crore, employee benefits at ₹600.6 crore among others.
For the nine-month period ended December 2025, the company posted PAT of ₹2,033 crore, up from ₹1,876 crore in the comparable period, while total income reached ₹1,281.9 crore, versus ₹1,182.2 crore a year ago.
In a separate exchange filing, the company said that it launched a new 90-bed hospital in Electronic City, Bengaluru, marking its fifth facility in the city, as it expands regional capacity and network density.
Shares of Rainbow Children’s Medicare ended the day 0.04% below at ₹1,188 on the NSE.
/images/ppid_a911dc6a-image-176960359734713948.webp)
/images/ppid_a911dc6a-image-176960356339032498.webp)
/images/ppid_a911dc6a-image-176960352899812711.webp)
/images/ppid_59c68470-image-176960257078425636.webp)
/images/ppid_59c68470-image-176960253380081153.webp)
/images/ppid_59c68470-image-176960260891270787.webp)